Bellevue Life Sciences Stock Revenue
| BLAC Stock | 11.30 0.04 0.36% |
Bellevue Life Sciences fundamentals help investors to digest information that contributes to Bellevue Life's financial success or failures. It also enables traders to predict the movement of Bellevue Stock. The fundamental analysis module provides a way to measure Bellevue Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bellevue Life stock.
| Last Reported | Projected for Next Year |
Bellevue | Revenue |
Bellevue Life Sciences Company Revenue Analysis
Bellevue Life's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Bellevue Life Sciences reported 0.0 of revenue. This is 100.0% lower than that of the Capital Markets sector and about the same as Financials (which currently averages 0.0) industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Bellevue Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bellevue Life's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bellevue Life could also be used in its relative valuation, which is a method of valuing Bellevue Life by comparing valuation metrics of similar companies.Bellevue Life is currently under evaluation in revenue category among its peers.
Bellevue Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bellevue Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bellevue Life's managers, analysts, and investors.Environmental | Governance | Social |
Bellevue Fundamentals
| Return On Asset | -0.0298 | ||||
| Current Valuation | 48.64 M | ||||
| Shares Outstanding | 4.04 M | ||||
| Shares Owned By Insiders | 50.49 % | ||||
| Shares Owned By Institutions | 42.94 % | ||||
| Number Of Shares Shorted | 766 | ||||
| Price To Book | 3.14 X | ||||
| EBITDA | 944.59 K | ||||
| Net Income | 403.78 K | ||||
| Total Debt | 4.11 M | ||||
| Book Value Per Share | (0.69) X | ||||
| Cash Flow From Operations | (818.77 K) | ||||
| Short Ratio | 0.04 X | ||||
| Earnings Per Share | (0.09) X | ||||
| Market Capitalization | 45.75 M | ||||
| Total Asset | 36.63 M | ||||
| Retained Earnings | (3.91 M) | ||||
| Working Capital | (2.02 M) | ||||
| Net Asset | 36.63 M |
About Bellevue Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bellevue Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bellevue Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bellevue Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bellevue Life Sciences is a strong investment it is important to analyze Bellevue Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bellevue Life's future performance. For an informed investment choice regarding Bellevue Stock, refer to the following important reports:Check out Bellevue Life Piotroski F Score and Bellevue Life Altman Z Score analysis. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellevue Life. If investors know Bellevue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellevue Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Return On Assets (0.03) |
The market value of Bellevue Life Sciences is measured differently than its book value, which is the value of Bellevue that is recorded on the company's balance sheet. Investors also form their own opinion of Bellevue Life's value that differs from its market value or its book value, called intrinsic value, which is Bellevue Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellevue Life's market value can be influenced by many factors that don't directly affect Bellevue Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellevue Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bellevue Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellevue Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.